ABSTRACT
INTRODUCTION The World Health Organization defines acute flaccid paralysis syndrome as rapid onset of weakness of an individual’s extremities, often including weakness of the muscles of respiration and swallowing, progressing to maximum severity within 1–10 days. We carried out this observational study in a tertiary care center in North India with the aim of determining the etiology and outcome of Acute Flaccid Paralysis in adults.
METHODS In this observational study, all cases diagnosed with Acute flaccid paralysis admitted to the tertiary care center from 1st January 2015 till 30th June 2016 were enrolled. Ninety-seven consecutive patients of age above 18 years presenting with weakness of duration less than two weeks were enrolled after obtaining informed consent and various investigations were studied.
RESULTS The study analyzed data of 97 patients presenting with flaccid paralysis. They were analyzed for the demographic data, clinical features, investigations, electrophysiological data, and results of the treatment. The most common etiology of acute flaccid paralysis in this entire population was GBS, which was responsible for 50.5% of the cases, followed by the Hypokalemic paralysis (25.8%) followed by neuroparalytic snake bite (15.5%).In this study, 48% of patients with hypokalemic paralysis had a secondary cause for their condition. Primary hypokalemic periodic paralysis occurred in 52% of patients.
CONCLUSIONS In this observational study, GBS was found to be the most common cause for Acute Flaccid Paralysis followed by Neuroparalytic snake bite. Respiratory paralysis was an important risk factor associated with mortality.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Dayanand Medical College and Hospital's IRB committee gave approval for conducting the research.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The statistical analysis was carried out by author and co-author in conjunction with the Department of Research at DMCH.Ludhiana, India.
We do not have any study funding or sponsorship
Data Availability
There is full availability of all data referred to in the manuscript.
